Figure 2From: Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment The logarithmic declines from pretreatment hepatitis C virus (HCV) RNA by TaqMan and Amplicor 10-fold method assays within the initial 12 weeks during pegylated interferon alpha plus ribavirin treatment. White and black bars mean sustained virological response (SVR) and non-SVR patients, respectively.Back to article page